Biotech Acquisition Quick Ratio (BIOT) starting from the third quarter 2022 to third quarter 2021, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket
 


Biotech Acquisition Company  (NASDAQ: BIOT)
    Sector • Financial    Industry • Blank Checks
   Industry • Blank Checks
   Sector • Financial

Biotech Acquisition's Quick Ratio

BIOT's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


In the wake of the increase in Current Liabilities in the third quarter 2022, Quick Ratio fell to 0 a new company low.

Within Blank Checks industry 431 other companies have achieved higher Quick Ratio than Biotech Acquisition in third quarter 2022. While Quick Ratio total ranking in the third quarter 2022 has deteriorated compared to the prior quarter from 5820 to 6032.

Explain Quick Ratio?
How much Cash & cash equivalents BIOT´s has?
What are BIOT´s Current Liabilities?




BIOT Quick Ratio (Sep 30 2022)
Q3
(Jun 30 2022)
Q2
(Mar 31 2022)
Q1
(Dec 31 2021)
Q4
(Sep 30 2021)
Q3
Y / Y Current Liabilities Change 880.98 % 902.4 % 2638.35 % - -
Y / Y Cash & cash equivalent Change -96.73 % -99.82 % -99.95 % - -
Quick Ratio MRQ 0 0 0.05 0.29 1.12
BIOT's Total Ranking # 6032 # 5820 # 4919 # 1897 # 2128
Seq. Current Liabilities Change 5.91 % 49.56 % 607.71 % -12.49 % 8.23 %
Seq. Cash & cash equivalent Change 675.06 % -98.37 % 13.84 % -77.28 % -57.02 %



Quick Ratio third quarter 2022 Company Ranking
Within: No.
Blank Checks Industry # 432
Financial Sector # 1335
Overall Market # 6032


Quick Ratio Statistics
High Average Low
2.83 0.72 0
(Jun 30 2021)   (Jun 30 2022)




Financial Statements
Biotech Acquisition's Current Liabilities $ 4 Millions Visit BIOT's Balance sheet
Biotech Acquisition's Cash & cash equivalent $ 0 Millions Visit BIOT's Balance sheet
Source of BIOT's Sales Visit BIOT's Sales by Geography


Cumulative Biotech Acquisition's Quick Ratio

BIOT's Quick Ratio for the trailling 12 Months

BIOT Quick Ratio

(Sep 30 2022)
12 Months
(Jun 30 2022)
12 Months
(Mar 31 2022)
12 Months
(Dec 31 2021)
12 Months
(Sep 30 2021)
12 Months
Y / Y Current Liabilities TTM Growth 1115.73 % 1406.77 % 3876.01 % - -
Y / Y Cash & cash equivalent TTM Growth -99.91 % -99.74 % -99.33 % - -
Quick Ratio TTM 0.02 0.1 0.48 213.95 300.91
Total Ranking TTM # 4736 # 4729 # 3127 # 951 # 0
Seq. Current Liabilities TTM Growth 50.84 % 92.73 % 197.24 % 40.7 % 86.94 %
Seq. Cash & cash equivalent TTM Growth -64.92 % -60.92 % -99.34 % 0.04 % 0.17 %


On the trailing twelve months basis Due to rise in Current Liabilities in the Q3 2022 to $3.52 millions, cumulative Quick Ratio decreased to 0.02 below the Biotech Acquisition Company average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Blank Checks industry 382 other companies have achieved higher Quick Ratio than Biotech Acquisition. While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the second quarter 2022 from 4729 to 4736.

Explain Quick Ratio?
How much Cash & cash equivalents BIOT´s has?
What are BIOT´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Blank Checks Industry # 383
Financial Sector # 525
Within the Market # 4736


trailing twelve months Quick Ratio Statistics
High Average Low
1.09 0.42 0.02
(Dec 31 2021)   (Sep 30 2022)




Companies with similar Quick Ratio in the quarter ending Sep 30 2022, within Blank Checks Industry Quick RatioSep 30 2022 MRQ Cash & cash equivalentSep 30 2022 MRQ Current Liabilities
Public Co Management Corp  0.01 $ 0.004  Millions$ 0.433  Millions
Ig Acquisition Corp   0.01 $ 0.028  Millions$ 2.820  Millions
Natural Order Acquisition Corp   0.01 $ 0.009  Millions$ 0.875  Millions
Primavera Capital Acquisition Corporation  0.01 $ 0.059  Millions$ 6.057  Millions
Tzp Strategies Acquisition Corp   0.01 $ 0.033  Millions$ 3.462  Millions
Ibere Pharmaceuticals  0.01 $ 0.004  Millions$ 0.469  Millions
Kadem Sustainable Impact Corporation  0.01 $ 0.040  Millions$ 4.207  Millions
Mdh Acquisition Corp   0.01 $ 0.036  Millions$ 3.989  Millions
Authentic Equity Acquisition Corp   0.01 $ 0.008  Millions$ 0.920  Millions
Jack Creek Investment Corp   0.01 $ 0.052  Millions$ 6.034  Millions
Cf Acquisition Corp Iv  0.01 $ 0.025  Millions$ 3.174  Millions
Aries I Acquisition Corporation  0.01 $ 0.026  Millions$ 3.551  Millions
High Sierra Technologies Inc   0.01 $ 0.004  Millions$ 0.501  Millions
High Sierra Technologies Inc   0.01 $ 0.004  Millions$ 0.501  Millions
Hennessy Capital Investment Corp Viii  0.01 $ 0.072  Millions$ 12.591  Millions
Monterey Innovation Acquisition Corp   0.01 $ 0.544  Millions$ 97.422  Millions
Lnpr Group Inc 0.00 $ 0.001  Millions$ 0.225  Millions
Oca Acquisition Corp 0.00 $ 0.015  Millions$ 3.198  Millions
Marlin Technology Corporation 0.00 $ 0.005  Millions$ 1.342  Millions
Arya Sciences Acquisition Corp Iv 0.00 $ 0.023  Millions$ 6.027  Millions
Biotech Acquisition Company 0.00 $ 0.013  Millions$ 3.518  Millions
Lightjump Acquisition Corporation 0.00 $ 0.015  Millions$ 4.155  Millions
Greencity Acquisition Corporation 0.00 $ 0.009  Millions$ 3.004  Millions
Gx Acquisition Corp Ii 0.00 $ 0.013  Millions$ 4.555  Millions
Sandston Corp 0.00 $ 0.000  Millions$ 0.028  Millions
Fortistar Sustainable Solutions Corp 0.00 $ 0.003  Millions$ 1.787  Millions
Mountain Crest Acquisition Corp Iii 0.00 $ 0.000  Millions$ 0.154  Millions
G Squared Ascend I Inc 0.00 $ 0.004  Millions$ 2.659  Millions
Austerlitz Acquisition Corporation Ii 0.00 $ 0.001  Millions$ 0.910  Millions

Date modified: 2026-06-22T16:30:29+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.